open access

Vol 11, Supp. G (2015)
Case report
Published online: 2015-12-17
Get Citation

Durable disease stabilization associated with octreotide LAR treatment in a patient with metastatic carcinoid of the small intestine

Bogumiła Czartoryska-Arłukowicz

open access

Vol 11, Supp. G (2015)
CASE REPORT
Published online: 2015-12-17

Abstract

59-year old woman was admitted to the Comprehensive Cancer Center in Bialystok in October 2001. Carcinoid of the small intestine with liver metastases was diagnosed. The patient under went right hemicolectomy and partial resection of the small intestine. Treatment with octreotide LAR was initiated because of severe symptoms related to serotonin syndrome. Moreover, the patient has been treated with two doses of somatostatin analogue radioisotope (3,65GBq Y-90 DOTA TATE). Durable disease stabilization is being observed until now — above 12 years after octreotide LAR therapy initiation. Currently, treatment with octreotide LAR is being continuated.

Abstract

59-year old woman was admitted to the Comprehensive Cancer Center in Bialystok in October 2001. Carcinoid of the small intestine with liver metastases was diagnosed. The patient under went right hemicolectomy and partial resection of the small intestine. Treatment with octreotide LAR was initiated because of severe symptoms related to serotonin syndrome. Moreover, the patient has been treated with two doses of somatostatin analogue radioisotope (3,65GBq Y-90 DOTA TATE). Durable disease stabilization is being observed until now — above 12 years after octreotide LAR therapy initiation. Currently, treatment with octreotide LAR is being continuated.

Get Citation

Keywords

octreotide, durable disease stabilization, carcinoid, small intestine

About this article
Title

Durable disease stabilization associated with octreotide LAR treatment in a patient with metastatic carcinoid of the small intestine

Journal

Oncology in Clinical Practice

Issue

Vol 11, Supp. G (2015)

Article type

Case report

Pages

3-5

Published online

2015-12-17

Keywords

octreotide
durable disease stabilization
carcinoid
small intestine

Authors

Bogumiła Czartoryska-Arłukowicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl